175 related articles for article (PubMed ID: 38689088)
1. TLR7-dependent eosinophil degranulation links psoriatic skin inflammation to small intestinal inflammatory changes in mice.
Kim HJ; Jang J; Na K; Lee EH; Gu HJ; Lim YH; Joo SA; Baek SE; Roh JY; Maeng HJ; Kim YH; Lee YJ; Oh BC; Jung Y
Exp Mol Med; 2024 May; 56(5):1164-1177. PubMed ID: 38689088
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
3. A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice.
Griffith AD; Zaidi AK; Pietro A; Hadiono M; Yang JS; Davis R; Popkin DL
Sci Rep; 2018 Sep; 8(1):14451. PubMed ID: 30262916
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils Accelerate Pathogenesis of Psoriasis by Supporting an Inflammatory Milieu that Promotes Neutrophil Infiltration.
Kim HJ; Roh JY; Jung Y
J Invest Dermatol; 2018 Oct; 138(10):2185-2194. PubMed ID: 29580867
[TBL] [Abstract][Full Text] [Related]
5. Rutaecarpine inhibited imiquimod-induced psoriasis-like dermatitis via inhibiting the NF-κB and TLR7 pathways in mice.
Li Y; Zhang G; Chen M; Tong M; Zhao M; Tang F; Xiao R; Wen H
Biomed Pharmacother; 2019 Jan; 109():1876-1883. PubMed ID: 30551443
[TBL] [Abstract][Full Text] [Related]
6.
Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
[TBL] [Abstract][Full Text] [Related]
7. Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis.
Zhu Y; Wu Z; Yan W; Shao F; Ke B; Jiang X; Gao J; Guo W; Lai Y; Ma H; Chen D; Xu Q; Sun Y
EMBO Mol Med; 2022 Mar; 14(3):e14455. PubMed ID: 34936223
[TBL] [Abstract][Full Text] [Related]
8. Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease models.
Straß S; Geiger J; Martorelli M; Geiger S; Cloos N; Keppler M; Fischer T; Riexinger L; Schwamborn A; Guezguez J; Späth N; Cruces S; Guse JH; Sandri TL; Burnet M; Laufer S
Inflammopharmacology; 2023 Apr; 31(2):799-812. PubMed ID: 36943539
[TBL] [Abstract][Full Text] [Related]
9. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammation in asocial BTBR T
Nadeem A; Ahmad SF; El-Sherbeeny AM; Al-Harbi NO; Bakheet SA; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():8-17. PubMed ID: 29287831
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil-dependent skin innervation and itching following contact toxicant exposure in mice.
Lee JJ; Protheroe CA; Luo H; Ochkur SI; Scott GD; Zellner KR; Raish RJ; Dahl MV; Vega ML; Conley O; Condjella RM; Kloeber JA; Neely JL; Patel YS; Maizer P; Mazzolini A; Fryer AD; Jacoby NW; Jacoby DB; Lee NA
J Allergy Clin Immunol; 2015 Feb; 135(2):477-87. PubMed ID: 25129680
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
Gilliet M; Conrad C; Geiges M; Cozzio A; Thürlimann W; Burg G; Nestle FO; Dummer R
Arch Dermatol; 2004 Dec; 140(12):1490-5. PubMed ID: 15611427
[TBL] [Abstract][Full Text] [Related]
13. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques.
De Meyer I; Martinet W; Schrijvers DM; Timmermans JP; Bult H; De Meyer GR
Basic Res Cardiol; 2012 May; 107(3):269. PubMed ID: 22543675
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
16. Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice.
Wohn C; Ober-Blöbaum JL; Haak S; Pantelyushin S; Cheong C; Zahner SP; Onderwater S; Kant M; Weighardt H; Holzmann B; Reizis B; Becher B; Prens EP; Clausen BE
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10723-8. PubMed ID: 23754427
[TBL] [Abstract][Full Text] [Related]
17. Eosinophils may play regionally disparate roles in influencing IgA(+) plasma cell numbers during large and small intestinal inflammation.
Forman R; Bramhall M; Logunova L; Svensson-Frej M; Cruickshank SM; Else KJ
BMC Immunol; 2016 May; 17(1):12. PubMed ID: 27245920
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte proline-rich protein modulates immune and epidermal response in imiquimod-induced psoriatic skin inflammation.
Matsuno A; Sumida H; Nakanishi H; Ikeyama Y; Ishii T; Omori I; Saito H; Iwasawa O; Sugimori A; Yoshizaki A; Katoh H; Ishikawa S; Sato S
Exp Dermatol; 2023 Dec; 32(12):2121-2130. PubMed ID: 37926955
[TBL] [Abstract][Full Text] [Related]
19. Complement component 3 prevents imiquimod-induced psoriatic skin inflammation by inhibiting apoptosis in mice.
Zheng QY; Liang SJ; Xu F; Yang Y; Feng JL; Shen F; Zhong Y; Wu S; Shu Y; Sun DD; Xu GL
Int Immunopharmacol; 2020 Aug; 85():106692. PubMed ID: 32535539
[TBL] [Abstract][Full Text] [Related]
20. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
